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Introduction
Lung cancer is the most common malignancy and has been 
the most common cause of deaths from cancer in the past few 
decades.1 A total of 1.8 million new cases were estimated in 
2012 which includes 12.9% of all newly diagnosed cancers. 
The patient’s five-year survival rate is much lower than 
that of other cancers (17.8%).2,3 The most important risk 
factors of lung cancer include tobacco smoking and aging. 
In addition to the mentioned factors, genetic background 
plays an important role in the development of this disease.4 
Matrix metalloproteases (MMPs) are a large family of zinc 
dependent proteinases consisting of more than 26 members; 
they act based on digestion of extracellular matrix (ECM) 
and basement membrane components. Since the ECM acts as 
an anchorage for stabilization of cells, increased MMPs level 
are required for invasion and migration of cancer cells.5,6 The 
MMPs also act on cleavage of cell adhesion molecules such as 
growth factors, cell surface receptors, chemokines/cytokines 
and they may regulate angiogenesis in cancer process through 
the activation of proangiogenic factors.7-9 The MMP-9 (type 
IV collagenase) is one of the most important members of 
the metalloproteinase family which plays a role in degrading 
of both basement membrane components and collagen 
attachments around the cells. A cytosine (C) to thymine 
(T) base substitution at position -1562 in the upstream of 
the MMP-9 transcription initiation site (MMP-9–1562C/T) 
causes MMP-9 over expression.10 
Several studies have reported that CT and TT genotypes 
of MMP-9–1562C/T polymorphisms are associated with the 
occurrence and progression of some cancers, including colon, 
breast and lung cancer.11-13 In previous studies, a significant 
association was found between the T allele and occurrence of 
breast cancer in the Iranian population. It was also found that 
T allele increases the plasma MMP-9 levels in breast cancer 
patients.14,15 On the other hand, there are reports about the 
association between the presence of MMP-9 promoter T allele 
and lower risk of lung cancer in the Spanish,16 Turkish17 and 
French populations.18 Another study published by Chinese 
researchers did not suggest a relevant association between 
MMP-9–1562 C/T polymorphism and lung cancer.19 
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Abstract
Introduction: Matrix metalloproteinases (MMPs) are a family of zinc dependent proteinase. Several studies have reported the association 
between the single nucleotide polymorphisms(C/T) -1562 in the MMP-9 promoter and the risk of cancer. In this study we decided to carry out a 
comprehensive meta-analysis to obtain a reasonable result about the association between this polymorphism and the risk of lung cancer.
Materials and Methods: A complete literature review was conducted within the databases of ISI Web of Knowledge, google scholar and PubMed 
for studies on lung cancer published from 2002 to 2018. A meta-analysis was conducted which included more than 3000 case and control 
subjects. The pooled odds ratio (OR) and 95% confidence intervals (CI) were used for dominant, recessive and co-dominant MMP-9 genotypes to 
assess the strength of the association.
Results: Analysis indicated no significant association between MMP-9-1562C/T polymorphism and the risk of lung cancer, dominant model; 
[CT+TT/CC]: OR = 0.972, 95% CI = 0.811–1.164, recessive model [CC+CT/TT] OR= 1.027, 95% CI = 0.651–1.618 and co-dominant model [TT/
CC] OR = 0.983, 95% CI = 0.550–1.755. 
Conclusions: No association was observed between the MMP9-1562 C/T polymorphism and the incidence of lung cancer. Meta-analysis 
demonstrated that this polymorphism can’t serve as a diagnostic marker for lung cancer.
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